Showing results (661-670 of 5,983) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|June 15, 2017
IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal AdenocarcinomaKristen B Long, Graham Tooker, Evan Tooker, et al.
Molecular Cancer Therapeutics|June 16, 2017
Combination Treatment with Orlistat-Containing Nanoparticles and Taxanes Is Synergistic and Enhances Microtubule Stability in Taxane-Resistant Prostate Cancer CellsJoshua J Souchek, Amanda L Davis, Tanner K Hill, et al.
Molecular Cancer Therapeutics|June 16, 2017
Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT ProgressionBilal Bin Hafeez, Aditya Ganju, Mohammed Sikander, et al.
Molecular Cancer Therapeutics|June 20, 2017
Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal CancerCristina Santos, Daniel Azuara, Rocio Garcia-Carbonero, et al.
Molecular Cancer Therapeutics|February 11, 2010
Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptorsSom D Sharma, Syed M Meeran, Santosh K Katiyar
Molecular Cancer Therapeutics|June 4, 2017
The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic TargetMelanie A Blevins, Mingxia Huang, Rui Zhao
Molecular Cancer Therapeutics|March 4, 2010
Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeresMarcy A Mitchell, Jay E Johnson, Kara Pascarelli, et al.
Molecular Cancer Therapeutics|March 4, 2010
Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cellsShengbing Huang, Frank A Sinicrope
Molecular Cancer Therapeutics|March 4, 2010
IFN-beta restricts tumor growth and sensitizes alveolar rhabdomyosarcoma to ionizing radiationThomas L Sims, Mackenzie McGee, Regan F Williams, et al.
Molecular Cancer Therapeutics|August 11, 2018
Unraveling the Interaction between Carboxylesterase 1c and the Antibody-Drug Conjugate SYD985: Improved Translational PK/PD by Using Ces1c Knockout MiceRuud Ubink, Eef H C Dirksen, Myrthe Rouwette, et al.
Pageof 599